Description

Exploring transitions and intersections of the pharmaceutical and nutraceutical industries.  

The pharma and nutra industries are increasingly merging, adopting aspects of the other to meet consumer demands for solutions for health. Pharma companies are entering the health and nutrition space and vice versa. To understand more about this pharma to nutra transition and how it is impacting the nutraceutical industry, we talked to Dilip Gosh, the principal consultant at NutriConnect in Australia.  

Tune in to hear more about: 

• How nutraceuticals are being reshaped and linked to the pharma industry  
• The market dynamics and drivers for the pharma to nutra transition  
• How emerging markets are expanding into this fast-growing space and insights about market perspective, consumer and branding  
• Scope overview on the current pharma ‘high-risk, high-margin’ business model to ‘low-cost, high-volume’ nutra business, and the ‘blockbuster’ concept  
• The regulatory landscape and considerations around pharma to nutra changes  

Guest: Dilip Ghosh, Principal Consultant at NutriConnect

If you like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it. 

For more content from Vitafoods Insights, make sure to check our website: https://www.vitafoodsinsights.com/ 

To learn more about sponsorships opportunities, click here and make sure to check our media kit.